Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-β/δ antagonist GSK3787

…, CR Anderson, GH Perdew, FJ Gonzalez, R Müller… - Molecular …, 2010 - ASPET
The availability of high-affinity agonists for peroxisome proliferator-activated receptor-β/δ (PPARβ/δ)
has led to significant advances in our understanding of the functional role of PPARβ/…

[HTML][HTML] CD8+ T cells mediate RAS-induced psoriasis-like skin inflammation through IFN-γ

…, FJ Horvath, MA Podolsky, CR Anderson… - Journal of Investigative …, 2013 - Elsevier
The RAS signaling pathway is constitutively activated in psoriatic keratinocytes. We expressed
activated H-RAS V12G in suprabasal keratinocytes of adult mice and observed rapid …

Differential hepatic effects of perfluorobutyrate mediated by mouse and human PPAR-α

…, DJ Ehresman, JL Butenhoff, CR Anderson… - Toxicological …, 2009 - academic.oup.com
Perfluorobutryate (PFBA) is a short chain perfluoroalkyl carboxylate that is structurally
similar to perfluorooctanoate. Administration of PFBA can cause peroxisome proliferation, …

Effect of prenatal peroxisome proliferator-activated receptor α (PPARα) agonism on postnatal development

PS Palkar, CR Anderson, CH Ferry, FJ Gonzalez… - Toxicology, 2010 - Elsevier
Recent work indicates that PPARα is required for perfluorooctanoic acid (PFOA)-induced
postnatal lethality resulting from prenatal exposure. The present study tested the hypothesis …

[HTML][HTML] Cholestasis induces reversible accumulation of periplakin in mouse liver

…, T Matsubara, YM Shah, S Ahn, CR Anderson… - BMC …, 2013 - Springer
Background Periplakin (PPL) is a rod-shaped cytolinker protein thought to connect cellular
adhesion junctional complexes to cytoskeletal filaments. PPL serves as a structural …

[PDF][PDF] Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps

B Chen, S Cherie'R, ET McKinley, AJ Simmons… - Cell, 2021 - cell.com
Colorectal cancers (CRCs) arise from precursor polyps whose cellular origins, molecular
heterogeneity, and immunogenic potential may reveal diagnostic and therapeutic insights …

[PDF][PDF] Differential hepatic effects of perfluorobutyrate (PFBA) mediated by mouse and human PPARα

…, SC Chang, DJ Ehresman, JL Butenhoff, CR Anderson… - Citeseer
Perfluorobutryate (PFBA) is a short chain perfluoroalkyl carboxylate that is structurally
similar to perfluorooctanoate. Administration of PFBA can cause peroxisome proliferation, …

[HTML][HTML] The cell cycle inhibitor p21waf1 binds to the myc and cdc25A promoters upon DNA damage and induces transcriptional repression

A Vigneron, J Cherier, B Barré, E Gamelin… - Journal of Biological …, 2006 - ASBMB
In addition to its function as a cyclin-dependent kinase (cdk) inhibitor, p21 waf1 fulfills
additional roles involved in DNA replication and transcriptional regulation that could also …

Minimization of indoor temperatures and total solar insolation by optimizing the building orientation in hot climate

…, T Benouaz, R Belarbi, MK Cherier - Engineering …, 2014 - Taylor & Francis
In order to reduce the energy load, understanding the overall architectural design features
and optimizing building orientation are important. They are guided by natural elements like …

[HTML][HTML] The c-Jun/RHOB/AKT pathway confers resistance of BRAF-mutant melanoma cells to MAPK inhibitors

A Delmas, J Cherier, M Pohorecka… - Oncotarget, 2015 - ncbi.nlm.nih.gov
The response of BRAF-mutant melanoma patients to BRAF inhibitors is dramatically impaired
by secondary resistances and rapid relapse. So far, the molecular mechanisms driving …